At the Nandu Power 2013 annual performance briefing, Nandu Power Finance Director and Secretary-General Wang Yingjiao said on Monday that the sales of electric bicycle batteries in 2013 was 1.6 billion, the profit was 83 million, and the sales of new energy vehicles were about 30 million.
For the lithium battery for new energy vehicles that are highly regarded by the market, Wu Xianzhang, the company's chief engineer, said that the company's new lithium-ion film technology is now in the batch verification stage and has not yet been used for mass production.
Chen Bo, general manager of the company, said that the company's lithium battery has increased in overseas and domestic markets in 2013. The contribution from overseas markets is particularly prominent. The company has further strengthened its lithium battery promotion and actively expanded the application fields of lithium battery products. To ensure the development of lithium battery business.
Regarding whether to cooperate with Tesla, Chen Bo said: "Tesla intends to build a large-scale battery factory, and the company has no cooperation plan at present."
When it comes to the relationship between the development of new energy vehicles and the development of the company, Chen Bo said that the company attaches importance to the development of the new energy automobile industry. The development model and plan of China's new energy vehicles are still not mature, and the company is also actively evaluating and following up. Targeted market and technology investments.
Chen Bo further said that the new energy vehicles include hybrid vehicles and pure electric vehicles. The two schemes and development models are also different. From the perspective of the feasibility of personal consumption of new energy vehicles, short-term hybrid vehicles are more realistic.
"Battery is the focus of the company's future development in the field of power and energy storage. In the electric bicycle battery market, the company's production and sales have been improving, and the company hopes to further develop in this market." Chen Bo said.
Nandu Power's 2013 annual results forecast shows that the net profit attributable to shareholders of listed companies has changed by 0%-20% over the same period of the previous year (profit of RMB 12,608,100 – RMB 1,513,700,000). It is estimated that the company's net profit attributable to shareholders of listed companies in 2013 was 13,046,200 yuan, an increase of 3.47% over the same period of 2012, which is within the expected range of company performance forecast.
Intravenous Injection Of Human Immunoglobulin
[Composition]
The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. It contains a suitable amount of glucose or maltose as stabilizer (see table below), but does not contain any antiseptic or antibiotic. The distribution of IgG subclasses is close to the serum level of normal subjects and maintains the bioactivity of Fc fragment of IgG.
[Indications]
1. Primary
agammaglobulinemia, such as X-linked hypogammaglobulinemia,
common variant immunodeficiency diseases, immunoglobulin G subclass deficiency,
etc.
2. Secondary
immunoglobulin deficiency diseases, such as severe infection, septicemia of
newborn, etc
Intravenous Injection Of Human Immunoglobulin,Intravenous Immunoglobulin,High-Quality Effective Intravenous Immunoglobulin,Human Immunoglobulin For Intravenous Injection
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com